RACIAL/ETHNIC DIFFERENCES IN USE OF ADJUVANT HORMONAL THERAPY AMONG WOMEN WITH ESTROGEN RECEPTOR-POSITIVE (ER plus ) BREAST CANCER

被引：0
|
作者：
Livaudais, J. [1 ]
Li, C. [1 ]
John, E. [1 ]
Daly, M. [1 ]
Terry, M. [1 ]
Buys, S. [1 ]
Thompson, B. [1 ]
LaCroix, A. [1 ]
Habel, L. [1 ]
Coronado, G. [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 2010年 / 171卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 50 条
  • [41] Adjuvant endocrine monotherapy (ET) versus adjuvant breast radiation (RT) alone in healthy older women with stage I, estrogen receptor-positive (ER plus ) breast cancer: An analysis of the National Cancer Database (NCDB).
    Bui, Anthony H.
    Chadha, Manjeet
    Shao, Theresa H.
    Gerber, Naamit K.
    Cate, Sarah P.
    Boolbol, Susan K.
    Zubizarreta, Nicole J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [42] Adjuvant therapy with aromatase inhibitors in postmenopausal, estrogen receptor-positive breast cancer patients: upfront or sequential?
    Dediu, M.
    Median, D.
    Alexandru, A.
    Vremes, G.
    Gal, C.
    Gongu, M.
    JOURNAL OF BUON, 2009, 14 (03): : 375 - 379
  • [43] Avoidance of Negative Results in Adjuvant Endocrine Therapy Trials for Estrogen Receptor-Positive Breast Cancer Reply
    Smith, Ian E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (23) : 2719 - +
  • [44] A phase I study of the AKT inhibitor MK-2206 plus hormonal therapy in postmenopausal women with estrogen receptor positive (ER plus ) metastatic breast cancer (MBC)
    Ma, Cynthia X.
    Gao, Feng
    Naughton, Michael
    Pluard, Timothy J.
    Sorscher, Steven
    Creekmore, Allison N.
    Guo, Zhanfang
    Dehdashti, Farrokh
    Park, Ben Ho
    Lockhart, Albert C.
    Doyle, L. Austin
    Ellis, Matthew J.
    Erlanger, Bracha
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [45] Acquired RBI mutations in estrogen receptor-positive (ER plus ) clinically advanced and metastatic breast cancer (MBC).
    McGregor, Kimberly
    Sokol, Ethan
    Danziger, Natalie
    Pavlick, Dean
    Elvin, Julia Andrea
    Vergilio, Jo-Anne
    Killian, Jonathan Keith
    Lin, Douglas I.
    Williams, Erik Abraham
    Ramkissoon, Shakti H.
    Severson, Eric Allan
    Hemmerich, Amanda
    Duncan, Daniel
    Huang, Richard
    Chung, Jon
    Reddy, Venkataprasanth P.
    Venstrom, Jeffrey
    Schrock, Alexa Betzig
    Alexander, Brian Michael
    Ross, Jeffrey S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [46] Adjuvant Endocrine Therapy of Perimenopausal and Recently Postmenopausal Women With Hormone Receptor-Positive Breast Cancer
    Pan, Kathy
    Chlebowski, Rowan T.
    CLINICAL BREAST CANCER, 2014, 14 (03) : 147 - 153
  • [47] Review of bone health in women with estrogen receptor-positive breast cancer receiving endocrine therapy
    Malagrino, Matteo
    Zavatta, Guido
    WOMENS HEALTH, 2023, 19
  • [48] Treatment of Estrogen Receptor-Positive Breast Cancer
    Lumachi, F.
    Brunello, A.
    Maruzzo, M.
    Basso, U.
    Basso, S. M. M.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (05) : 596 - 604
  • [49] Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
    Datta, Jharna
    Willingham, Natalie
    Manouchehri, Jasmine M.
    Schnell, Patrick
    Sheth, Mirisha
    David, Joel J.
    Kassem, Mahmoud
    Wilson, Tyler A.
    Radomska, Hanna S.
    Coss, Christopher C.
    Bennett, Chad E.
    Ganju, Ramesh K.
    Sardesai, Sagar D.
    Lustberg, Maryam
    Ramaswamy, Bhuvaneswari
    Stover, Daniel G.
    Cherian, Mathew A.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [50] The choice of systemic adjuvant therapy in receptor-positive early breast cancer
    Dellapasqua, S
    Castiglione-Gertsch, M
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (03) : 357 - 364
12345